Results 11 to 20 of about 1,103,970 (339)

Empagliflozin in acute myocardial infarction: the EMMY trial

European Heart Journal, 2022
Aims Sodium–glucose co-transporter 2 inhibition reduces the risk of hospitalization for heart failure and for death in patients with symptomatic heart failure.
D. von Lewinski, E. Kolesnik, N. Tripolt, P. Pferschy, M. Benedikt, M. Wallner, H. Alber, R. Berger, M. Lichtenauer, C. Saely, D. Moertl, Pia Auersperg, C. Reiter, T. Rieder, J. Siller-Matula, Gloria M. Gager, M. Hasun, F. Weidinger, T. Pieber, P. Zechner, M. Herrmann, A. Zirlik, R. Holman, A. Oulhaj, H. Sourij   +24 more
semanticscholar   +1 more source

Identification of monocyte-associated genes as predictive biomarkers of heart failure after acute myocardial infarction

BMC Medical Genomics, 2021
Background Acute myocardial infarction (AMI) is a major contributor of heart failure (HF). Peripheral blood mononuclear cells (PBMCs), mainly monocytes, are the essential initiators of AMI-induced HF.
Qixin Chen, Qijin Yin, Junxian Song, Chuanfen Liu, Hong Chen, Sufang Li   +5 more
doaj   +1 more source

Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy

Frontiers in Cardiovascular Medicine, 2022
BackgroundPulmonary hypertension (PH) is a rare but life-threatening adverse event (AE) of dasatinib, but the associated variables are not clear. This study aimed to explore the variables associated with PH by echocardiography in patients with chronic ...
Wenying Jin, Sen Yang, Chao Yu, Tiangang Zhu, Qian Jiang, Qian Jiang   +5 more
doaj   +1 more source

Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation : A Prospective, Multicenter, Observational Study [PDF]

, 2023
Dr Berry acknowledges British Heart Foundation support (grant RE/18/6134217). Dr Artico received funding from the European Association of Cardiovascular Imaging (EACVI research grant App000073878).
OxAMI (Oxford Acute Myocardial Infarction Study) Investigators
core   +1 more source

Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study

Frontiers in Pharmacology, 2022
Introduction: Polypharmacy are commonly observed among older adults with cardiovascular disease. However, multiple medications lead to increased risk of drug-drug interactions (DDIs).
Mei Zhao, Chuan-Fen Liu, Chuan-Fen Liu, Chuan-Fen Liu, Yu-Fei Feng, Hong Chen, Hong Chen, Hong Chen   +7 more
doaj   +1 more source

High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction. [PDF]

, 2020
Background: The introduction of more sensitive cardiac troponin assays has led to increased recognition of myocardial injury in acute illnesses other than acute coronary syndrome.
Adamson, PD, Anand, A, Apple, F, Berry, C, Chapman, AR, Collinson, PO, Cruickshank, A, Ferry, AV, Findlay, I, Fox, KAA, Gray, A, High-STEACS Investigators, Keerie, C, Lee, KK, Maguire, D, McAllister, DA, Mills, NL, Newby, DE, Reid, A, Shah, ASV, Strachan, FE, Vallejos, CA, Weir, CJ   +22 more
core   +4 more sources

Cardiogenic Shock After Acute Myocardial Infarction: A Review.

Journal of the American Medical Association (JAMA), 2021
Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per year and is the leading cause of in-hospital mortality following acute myocardial infarction.
Marc D. Samsky, D. Morrow, A. Proudfoot, J. Hochman, H. Thiele, S. Rao   +5 more
semanticscholar   +1 more source

Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.

Journal of the American Medical Association (JAMA), 2022
Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection Studies have suggested an increased incidence of acute myocardial infarction (AMI) and ischemic stroke after COVID-19 infection related to an ...
Young-Eun Kim, K. Huh, Young-Joon Park, K. Peck, Jaehun Jung   +4 more
semanticscholar   +1 more source

Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association

Circulation, 2021
Over the past few decades, advances in pharmacological, catheter-based, and surgical reperfusion have improved outcomes for patients with acute myocardial infarctions.
Abdulla A. Damluji, Sean van Diepen, J. Katz, V. Menon, J. Tamis-Holland, M. Bakitas, Mauricio G. Cohen, L. Balsam, J. Chikwe   +8 more
semanticscholar   +1 more source

Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

New England Journal of Medicine, 2021
BACKGROUND: In patients with symptomatic heart failure, sacubitril-valsartan has been found to reduce the risk of hospitalization and death from cardiovascular causes more effectively than an angiotensin-converting-enzyme inhibitor.
M. Pfeffer, B. Claggett, E. Lewis, C. Granger, L. Køber, A. Maggioni, D. Mann, J. McMurray, J. Rouleau, S. Solomon, P. Steg, O. Berwanger, M. Čikeš, C. D. De Pasquale, C. East, A. Fernandez, K. Jering, U. Landmesser, R. Mehran, B. Merkely, F. Vaghaiwalla Mody, M. Petrie, I. Petrov, M. Schou, M. Senni, David Sim, P. van der Meer, M. Lefkowitz, Yinong Zhou, J. Gong, E. Braunwald   +30 more
semanticscholar   +1 more source